Church & Dwight Co
About: Church & Dwight is the leading global producer of baking soda. Beyond baking soda, the products in its portfolio have vast category reach, including laundry products, cat litter, oral care, deodorant, and nasal care, all sold under the Arm & Hammer brand. Its mix also includes Batiste, OxiClean, Vitafusion, WaterPik, Hero, and TheraBreath, which together with Arm & Hammer constitute around 70% of its annual sales and profits. Even as it works to extend the reach of its products, Church & Dwight still derives more than 80% of its sales from its home market in the US.
Employees: 5,750
Fund manager confidence
Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)
41% more first-time investments, than exits
New positions opened: 110 | Existing positions closed: 78
1% more funds holding
Funds holding: 1,012 [Q3] → 1,026 (+14) [Q4]
2% more capital invested
Capital invested by funds: $22.7B [Q3] → $23.1B (+$434M) [Q4]
1.97% less ownership
Funds ownership: 88.44% [Q3] → 86.47% (-1.97%) [Q4]
10% less funds holding in top 10
Funds holding in top 10: 10 [Q3] → 9 (-1) [Q4]
12% less repeat investments, than reductions
Existing positions increased: 341 | Existing positions reduced: 388
52% less call options, than puts
Call options by funds: $23.4M | Put options by funds: $49.2M
Research analyst outlook
6 Wall Street Analysts provided 1 year price targets over the past 3 months
6 analyst ratings
JP Morgan Andrea Teixeira 37% 1-year accuracy 22 / 59 met price target | 3%downside $106 | Underweight Maintained | 21 Feb 2025 |
Barclays Lauren Lieberman 43% 1-year accuracy 39 / 91 met price target | 15%downside $93 | Underweight Maintained | 4 Feb 2025 |
Truist Securities Bill Chappell 23% 1-year accuracy 6 / 26 met price target | 5%upside $115 | Buy Maintained | 3 Feb 2025 |
Stifel Mark Astrachan 38% 1-year accuracy 11 / 29 met price target | 4%downside $105 | Hold Maintained | 3 Feb 2025 |
RBC Capital Nik Modi 44% 1-year accuracy 17 / 39 met price target | 4%downside $105 | Sector Perform Reiterated | 3 Feb 2025 |
Financial journalist opinion









